Navigation Links
Christos Mantzoros honored by Federation of the American Societies for Experimental Biology
Date:4/29/2011

BOSTON Christos Mantzoros, MD, DSc, Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center (BIDMC), delivered the Solomon A. Berson Distinguished Lectureship at the annual meeting of the Federation of American Societies for Experimental Biology (FASEB) held earlier this month in Washington, DC.

Named in honor of Dr. Solomon A. Berson, whose development of the methodologies for radioimmunoassay led to discoveries that have helped to shape our present-day understanding of Type II diabetes, the lectureship recognizes contributions at the forefront of endocrinology and metabolic disease. Mantzoros is the second BIDMC investigator to receive this honor, following Jeffrey S. Flier, MD, Dean of Harvard Medical School and member of BIDMC's Department of Endocrinology, Diabetes and Metabolism, who received the 2000 Solomon A. Berson Lectureship.

Mantzoros was honored for his work in the study of adipokines, hormones that are critically important in the pathogenesis of diabetes, obesity and associated disease states, including cardiovascular disease and malignancies. As the FASEB noted, "The Mantzoros group was the first to conclusively demonstrate the role of leptin in regulating the neuroendocrine response to energy deprivation in humans and that administration of leptin corrects neuroendocrine and reproductive abnormalities associated with acute and chronic energy deprivation in humans."

An internationally recognized expert on obesity and diabetes, Mantzoros is a leading translational researcher whose work has led to discoveries that are influencing the treatment of eating disorders and contributing to our understanding of the key role that leptin plays in primary physiological functions including reproduction, metabolism and bone formation.

"Chris has greatly advanced our understanding of body-weight regulation, energy homeostasis, adipokine biology and insulin resistance," notes BIDMC Chairman of Medicine Mark Zeidel, MD, PhD. "In bringing his leptin investigations from the laboratory into clinical trials, he has demonstrated how 'bench-to-bedside' discoveries can truly influence patient care and lead to new directions in medicine."

Director of the Human Nutrition Unit at BIDMC and the Joslin Diabetes Center, Mantzoros is also Chief of Endocrinology at the Boston VA Healthcare System and Professor of Environmental Health at the Harvard School of Public Health.

A graduate of the University of Athens Medical School where he received MD and DSc degrees, Mantzoros holds an MSc degree in Clinical Investigation from Harvard Medical School and an MSc degree in Epidemiology from the Harvard School of Public Health.

He is an elected member of the American Society for Clinical Investigation and is the recipient of numerous awards, including the 2008 Outstanding Investigator Award from the American Federation for Medical Research, the American Association of Clinical Endocrinology Frontiers in Science Award, the Novartis Award in Diabetes and Metabolic Disease, the Lilly Award from the North American Association for the Study of Obesity, and the Mead Johnson Award from the American Society for Nutrition.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
2. Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce
3. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
4. Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
5. Amerigroup CEO James Carlson Honored at Crystal Ball for a Cure Annual Gala
6. WebMD Health Foundation Honored as Leader in Health by CancerCare
7. Five Organizations Receive APAs Psychologically Healthy Workplace Award, Ten Honored for Best Practices
8. UBC scientist honored with BMJs Junior Doctor of the Year Award
9. JDRF Founder, Lee Ducat, To Be Honored at 40th Anniversary Gala in Philadelphia
10. Bright Horizons Honored as Company that Cares for Third Straight Year
11. Enovate Honored as One of the 2010 “Michigan 50 Companies to Watch”
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... The International Essential Tremor Foundation (IETF) will host a free ... The seminar will take place on Saturday, Aug. 26 at the Embassy Suites by ... run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care ... one of the leading causes of long term skin conditions, including cancer. ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... fat (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 ... its adipose filtration technology. The '398 and '324 patents cover methods and ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Sharon Kleyne, host ... and Your Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the ... of myopia in China. , The article by Zidor Aldama described the situation in ...
(Date:7/24/2017)... ... 2017 , ... A Southern California-based author has released a new book which ... has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights the ... above. , In “Memories,” readers get a firsthand look at what Michelle has been ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 2017 Locus Biosciences Inc. today announced the ... development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the round ... Internet services provider, and joined by the North Carolina ... product programs targeting antibiotic resistant infections and other microbiome-related ... Dr. Rodolphe Barrangou and Dr. Charles ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
(Date:7/1/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... be broadcast live over the Internet on Thursday, July 27, ... the quarterly results will be made available at 7:30 a.m. ... The live audio webcast can be accessed via Zimmer Biomet,s ... archived for replay following the conference call. ...
Breaking Medicine Technology: